These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11471125)

  • 1. Blood donor suitability and allogeneic whole blood donation.
    Newman B
    Transfus Med Rev; 2001 Jul; 15(3):234-44. PubMed ID: 11471125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying losses to the donated blood supply due to donor deferral and miscollection.
    Custer B; Johnson ES; Sullivan SD; Hazlet TK; Ramsey SD; Hirschler NV; Murphy EL; Busch MP
    Transfusion; 2004 Oct; 44(10):1417-26. PubMed ID: 15383013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
    Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
    Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of blood donor deferral causes in the Trinidad and Tobago National Blood Transfusion Service.
    Charles KS; Hughes P; Gadd R; Bodkyn CJ; Rodriguez M
    Transfus Med; 2010 Feb; 20(1):11-4. PubMed ID: 19788640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International variation in volunteer whole blood donor eligibility criteria.
    Karp JK; King KE
    Transfusion; 2010 Feb; 50(2):507-13. PubMed ID: 19788512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood donor well-being: a primary responsibility of blood collection agencies.
    Reiss RF
    Ann Clin Lab Sci; 2011; 41(1):3-7. PubMed ID: 21325247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pre-donation deferrals--a teaching hospital experience.
    Rabeya Y; Rapiaah M; Rosline H; Ahmed SA; Zaidah WA; Roshan TM
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):571-4. PubMed ID: 18564700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole blood donor deferral rate and characteristics of the Turkish population.
    Arslan O
    Transfus Med; 2007 Oct; 17(5):379-83. PubMed ID: 17725552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of temporary deferrals on future blood donation behavior across the donor life cycle.
    Clement M; Shehu E; Chandler T
    Transfusion; 2021 Jun; 61(6):1799-1808. PubMed ID: 33780022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-blood donation: blood donor suitability and adverse events.
    Newman BH
    Curr Hematol Rep; 2004 Nov; 3(6):437-43. PubMed ID: 15496278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt-Jakob disease deferral policies.
    O'brien SF; Chiavetta JA; Goldman M; Fan W; Nair RC; Sher GD; Vamvakas EC
    Transfusion; 2006 Mar; 46(3):461-8. PubMed ID: 16533291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of changing the age criteria for blood donors.
    Goldman M; Fournier E; Cameron-Choi K; Steed T
    Vox Sang; 2007 May; 92(4):368-72. PubMed ID: 17456161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and frequency of whole blood donations from elderly donors.
    Müller-Steinhardt M; Müller-Kuller T; Weiss C; Menzel D; Wiesneth M; Seifried E; Klüter H
    Vox Sang; 2012 Feb; 102(2):134-9. PubMed ID: 21806633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based selection criteria to protect blood donors.
    Eder A
    J Clin Apher; 2010; 25(6):331-7. PubMed ID: 20824625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in presentation rates, deferrals and return behaviour among Norwegian blood donors.
    Misje AH; Bosnes V; Heier HE
    Vox Sang; 2010 Apr; 98(3 Pt 1):e241-8. PubMed ID: 19807904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving safety for young blood donors.
    Eder AF
    Transfus Med Rev; 2012 Jan; 26(1):14-26. PubMed ID: 21872427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of donor deferrals for malaria on blood availability in the United States.
    Leiby DA; Nguyen ML; Notari EP
    Transfusion; 2008 Oct; 48(10):2222-8. PubMed ID: 18673351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term serologic follow-up of blood donors with biologic false reactivity on an anti-human T-cell lymphotropic virus Types I and II chemiluminescent immunoassay and implications for donor management.
    Kiely P; Thomas B; Kebede M
    Transfusion; 2008 Sep; 48(9):1833-41. PubMed ID: 18503614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical evaluation of informed consent forms for adult and minor aged whole blood donation used by United States blood centers.
    Shaz BH; Demmons DG; Hillyer CD
    Transfusion; 2009 Jun; 49(6):1136-45. PubMed ID: 19220819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovations in blood donor screening and blood collection.
    Smith JW; Forsberg JE; Gilcher RO
    Curr Hematol Rep; 2002 Nov; 1(2):129-33. PubMed ID: 12901134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.